COMMUNIQUÉS West-GlobeNewswire

BioStem Technologies, Inc. Completes 2016, 2017 Audit of Financial Statements
17/08/2018
Pompano Beach, FL., Aug. 17, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM), a global life sciences corporation, providing innovative technologies with a concentration in Pharmaceuticals and [...]
Golden Leaf Holdings Announces Acquisition of Combined Cultivation, Production and Retail License in California
17/08/2018
PORTLAND, Ore., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized [...]
American Pain Association President Selects Tree of Knowledge as CBD Supplier -- CFN Media
17/08/2018
SEATTLE, Aug. 17, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]
Welldoc® to Highlight Adoption of Digital Therapeutics for Improving Diabetes Care with Five Poster Presentations at AADE 2018 Annual Meeting
17/08/2018
Malinda Peeples, RN, MS, CDE, Welldoc’s Vice President of Clinical Services, Programs and Research Recognized Today with AADE Allene Van Son Distinguished Service Award BALTIMORE, Aug. 17, 2018 (GLOBE NEWSWIRE) -- [...]
Mateon Therapeutics Receives Notice of Partial Clinical Hold for OX1222 Study
17/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today [...]
Navamedic ASA: Invitation to presentation of second quarter 2018
17/08/2018
Navamedic ASA invites you to a presentation of the second quarter 2018 figures. The presentation will take place at Felix Konferansesenter, Aker Brygge, Oslo, Friday 24 August. The presentation will start at 08.00 The [...]
VPR Brands, LP Announces Second Quarter 2018 Results
17/08/2018
FORT LAUDERDALE, FL, Aug. 17, 2018 (GLOBE NEWSWIRE) -- VPR Brands, LP (OTC PINK: VPRB), a market leader specializing in accessories and vaporizers for essential oils, cannabis concentrates and extracts as well as [...]
Endocyte Announces Presentations at the American Chemical Society (ACS) National Meeting & Exposition
17/08/2018
WEST LAFAYETTE, Ind., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that two posters will [...]
Evolus Granted Approval of DWP-450 by Health Canada
17/08/2018
IRVINE, Calif., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced that Health Canada has granted approval of DWP-450 (prabotulinumtoxinA) for the [...]
Delcath Issues Letter to Stockholders
17/08/2018
NEW YORK, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH) (“Delcath” or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, [...]
The American Health Council Appoints Nicholas Avitabile, MD to Board of Physicians
17/08/2018
NEW YORK, Aug. 17, 2018 (GLOBE NEWSWIRE) -- The American Health Council appointed Nicholas Avitabile, MD to its Board of Physicians for his outstanding contributions to the medical field. An endocrinologist at Crystal [...]
Precipio Announces Second Quarter 2018 Financial Results and Provides Corporate Update
17/08/2018
Conference call with management to be held Thursday August 23, 2018 at 09:00 Eastern Time NEW HAVEN, Conn., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), has [...]
Emergent BioSolutions to Participate in Series of Near-Term Investor Conferences
17/08/2018
GAITHERSBURG, Md., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences [...]
Akari Announces First Quarter 2018 Financial Results and Update on its Growing Pipeline of Phase II and Phase III Clinical Trials
17/08/2018
Opened three clinical trials in 2018 Trials in which complement dysregulation is the primary disease driver CAPSTONE, the Phase III trial in naïve paroxysmal nocturnal hemoglobinuria (PNH), in which patient treatment [...]
C-RAD AB – Interim report January-June 2018
17/08/2018
C-RAD AB – Interim report January-June 2018 PROFITABLE QUARTER, REVENUE INCREASED BY 61 PERCENT SECOND QUARTER 2018 Order intake: 56.4 (49.3) MSEK, 14%. Revenues: 51.9 (32.2) MSEK, 61%. Operating profit: 2.0 (-4.1) MSEK [...]
Immunicum AB (publ) Interim Report April - June 2018
17/08/2018
Press Release 17 August 2018 Immunicum AB (publ) Interim Report April - June 2018 Significant Events During the Second Quarter Immunicum announced Publication of Scientific Review of Ilixadencel Approach in [...]
Terveystalo Plc: Terveystalo Group Half-Year Report January 1-June 30, 2018
17/08/2018
Terveystalo Plc Half-Year Report 17 August 2018 at 9:00 a.m. EEST Strong bottom line growth continued. Strengthened balance sheet supports preparations for the Attendo acquisition. Highlights of the second quarter, [...]
Motif Bio to Present Iclaprim Data at ESCMID/ASM Conference
17/08/2018
NEW YORK, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that iclaprim data will be presented [...]
Shire plc: Rule 2.9 Announcement
17/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 17 August 2018 [...]

Pages